CanSino Biologics, Inc. Class H Financial Overview
CanSino Biologics, Inc. Class H's market cap is currently HK$12.95B. The company's EPS TTM is HK$0.12107310379999998; its P/E ratio is -58.83; CanSino Biologics, Inc. Class H is scheduled to report earnings on October 27, 2025, and the estimated EPS forecast is HK$0.34. See an overview of income statement, balance sheet, and cash flow financials.
